NASDAQ: ADMA - ADMA Biologics, Inc.

Yield per half year: +201.59%
Sector: Healthcare

ADMA Biologics, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
 0 48.77 -100% -9.16 -100%
P/S 3.68 33.76 -89.11%
P/BV 7.02 4.82 45.7%
P/FCF 217.1 60.98 256.03%
Ev/Ebitda 34.7 -22.12 -256.86%
Ev/S 4.03 22.56 -82.15%
Ev/FCF 272.25 68.75 296.02%
E/P -0.0341 0.0178 -291.86%
IP Value Score
2.63/10
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
 11.6 4.83 140.24% -74.67 -115.54%
ROE -20.89 9.61 -317.42%
ROA -8.58 0.3359 -2653.85%
ROIC 0 7.63 -100%
ROS -10.94 -25.17 -56.54%
ROCE 16 15.33 4.36%
IP Profitability Score
1.5/10
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
2/10
 4.39 -3.67 -219.85% 0.4033 989.29%
Nеt Debt/Ebitda 3.01 -3.44 -187.4%
Debt/Ratio 0.3999 0.1972 102.84%
Debt/Equity 2.26 1.54 46.2%
Debt/Net Income -4.66 10.31 -145.23%
IP Debt Score
6.4/10
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
 0 0.5496 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5496
IP Dividend Score
0/10
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
10/10
 779.81 -56.89 -1470.73%
Growth impulse Ebitda 5 years -174.9 -64.81 169.87%
Growth impulse Net Income 5 years -39.55 -58.33 -32.2%
Growth impulse FCF 5 years -104.77 -47 122.91%
Growth impulse EPS 5 years -85.33 -32.41 163.28%
IP Growth Score
2/10
IP Score
2.51/10

Similar companies

Illumina

Nektar Therapeutics

Amarin

Mylan